Description Additional information Reviews (0) Attachment Description Research PeptideTri-AgonistLot Verified GL -3 RT Triple-Receptor Research Peptide A next-generation synthetic peptide engineered as a unimolecular agonist of three metabolic receptors simultaneously a new frontier in metabolic and obesity research
This is the dose where the triple-agonist mechanism is fully engaged, and the body needs the full 4-week adaptation window
Multiple Health Benefits Supports reproductive health, energy, antioxidant defense, circulation, and immunity
During the first two to four weeks, participants in trials have reported: Gastrointestinal effects: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort are among the most commonly reported side effects
There are patient savings programs, but not everyone qualifies
While the difference is modest, it suggests that female physiology may respond slightly better to the triple receptor mechanism